Cargando…
Hepcidin as a Sensitive and Treatment-Responsive Acute-Phase Marker in Patients with Bacteremia: A Pilot Study
Hepcidin regulates iron metabolism by inhibiting intestinal iron absorption and iron release from iron stores. In addition to iron overload, inflammatory conditions also up-regulate hepcidin synthesis, which may serve as an antimicrobial defense by reducing iron availability to the invading microbes...
Autores principales: | Koukoulas, Kreon, Lygoura, Vasiliki, Kartalidis, Philip, Gatselis, Nikolaos K., Petinaki, Efthymia, Dalekos, George N., Simos, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221808/ https://www.ncbi.nlm.nih.gov/pubmed/35741214 http://dx.doi.org/10.3390/diagnostics12061404 |
Ejemplares similares
-
Low Serum Hepcidin in Patients with Autoimmune Liver Diseases
por: Lyberopoulou, Aggeliki, et al.
Publicado: (2015) -
Lessons from pathophysiology: Use of individualized combination treatments with immune interventional agents to tackle severe respiratory failure in patients with COVID-19
por: Dalekos, George N., et al.
Publicado: (2021) -
FibroMeter scores are predictive noninvasive markers of advanced and significant liver fibrosis in patients with chronic viral hepatitis or metabolic dysfunction-associated steatotic liver disease
por: Arvaniti, Pinelopi, et al.
Publicado: (2023) -
ERK signaling controls productive HIF‐1 binding to chromatin and cancer cell adaptation to hypoxia through HIF‐1α interaction with NPM1
por: Koukoulas, Kreon, et al.
Publicado: (2021) -
The changing epidemiology of hepatitis B in Greece
por: Rigopoulou, Eirini I., et al.
Publicado: (2021)